Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Muscular weakness in the mdx mouse

F Muntoni1, A Mateddu, F Marchei

  • 1Istituto di Neuropsichiatria Infantile, Cagliari, Italy.

Journal of the Neurological Sciences
|December 1, 1993
PubMed
Summary

Young mdx mice exhibit significant muscle weakness and degeneration, but adapt to dystrophin deficiency, showing no detectable impairment later in life. This study highlights a critical early period for neuromuscular symptoms in mdx mice.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Refining functional phenotypes in an international cohort of untreated paediatric type 2 and 3 SMA patients using the Revised Hammersmith Scale.

Neuromuscular disorders : NMD·2026
Same author

Respiratory management in spinal muscular atrophy: development of a global outcome measure.

Neuromuscular disorders : NMD·2025
Same author

Corrigendum to "Assessing disease progression in Spinal Muscular Atrophy, current gaps, and opportunities: a narrative review" [NMD, volume 49, article 105341].

Neuromuscular disorders : NMD·2025
Same author

Assessing disease progression in spinal muscular atrophy, current gaps, and opportunities: a narrative review.

Neuromuscular disorders : NMD·2025
Same author

Mortality of symptomatic children with spinal muscular atrophy in the era of disease-modifying therapies.

Neuromuscular disorders : NMD·2025
Same author

Safety, tolerability and pharmacokinetics of eteplirsen in young boys aged 6-48 months with Duchenne muscular dystrophy amenable to exon 51 skipping.

Neuromuscular disorders : NMD·2023

Area of Science:

  • Biomedical Science
  • Animal Models
  • Muscle Physiology

Background:

  • Mdx mice are a model for Duchenne muscular dystrophy, typically showing minimal neuromuscular symptoms despite underlying muscle pathology.
  • Degenerative and regenerative processes occur in all skeletal muscles of mdx mice.

Purpose of the Study:

  • To investigate the spontaneous motility and treadmill motor activity of mdx mice from 15 days to 6 months of age.
  • To analyze the histological changes in proximal and distal muscle groups during the early critical motility period in mdx mice.

Main Methods:

  • Analysis of spontaneous motility and treadmill motor activity in mdx mice.
  • Detailed histological examination of muscle tissues from mdx mice.

Main Results:

Related Experiment Videos

  • Mdx mice experience extreme weakness between 2 and 5 weeks of age.
  • Histological analysis revealed extensive necrosis and regeneration in proximal muscles by 16-17 days, peaking at day 18.
  • After the critical period, motility and endurance in mdx mice, while lower than controls, were not statistically different up to 6 months.

Conclusions:

  • Dystrophin deficiency causes significant, but transient, muscle degeneration and weakness in early-life mdx mice.
  • Mdx mice adapt to dystrophin deficiency during development, exhibiting no detectable in vivo functional impairment by 6 months of age.